5.57
price down icon5.59%   -0.33
after-market After Hours: 5.75 0.18 +3.23%
loading

Briacell Therapeutics Corp Stock (BCTX) Financials Data

Income Statement
Quarterly
*All numbers in millions
Period End Date 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31
Period Length 3 Months 3 Months 3 Months 3 Months 3 Months
Revenues
-
- - - -
Operating Expenses
15.60%
9.8294
8.503 - 5.677 4.4863
Depreciation and Amortization
0.03%
0.00382
0.00382 - - -
Operating Income/Loss
15.60%
-9.8294
-8.503 -7.7058 -5.677 -4.4863
Nonoperating Income/Loss
110.28%
-1.4861
14.46 5.2871 0.7816 -7.3954
Income/Loss From Continuing Operations Before Tax
290.20%
-11.33
5.9589 -2.4187 -4.8954 -11.88
Income/Loss From Continuing Operations After Tax
290.20%
-11.33
5.9589 -2.4187 -4.8954 -11.88
Net Income/Loss
290.20%
-11.33
5.9589 -2.4187 -4.8954 -11.88
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
7.88%
-0.0393
-0.0427 - - -
Basic Average Shares
0.00%
15.98
15.98 0.1016 15.52 15.52
Diluted Average Shares
4.16%
15.98
16.67 0.1016 15.52 15.52
Basic Earnings Per Share
286.84%
-0.71
0.38 - - -0.77
Diluted Earnings Per Share
42.00%
-0.71
-0.50 -0.15 -0.32 -0.77
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Cap:     |  Volume (24h):